Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ayaka Asano"'
Autor:
Osamu Maehara, Shunsuke Ohnishi, Ayaka Asano, Goki Suda, Mitsuteru Natsuizaka, Koji Nakagawa, Masanobu Kobayashi, Naoya Sakamoto, Hiroshi Takeda
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 6, Pp 545-556 (2019)
CD133 is a cellular surface protein, which has been reported to be a cancer stem cell marker, and thus is considered a potential target for cancer treatment. Metformin, one of the biguanides used for the treatment of diabetes, is also known to reduce
Externí odkaz:
https://doaj.org/article/ca28a1a386bc4e6eaeaeadc671f67188
Autor:
Naoya Sakamoto, Koji Nakagawa, Goki Suda, Ayaka Asano, Masanobu Kobayashi, Mitsuteru Natsuizaka, Shunsuke Ohnishi, Hiroshi Takeda, Osamu Maehara
Publikováno v:
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 6, Pp 545-556 (2019)
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 6, Pp 545-556 (2019)
CD133 is a cellular surface protein, which has been reported to be a cancer stem cell marker, and thus is considered a potential target for cancer treatment. Metformin, one of the biguanides used for the treatment of diabetes, is also known to reduce
Autor:
Hideaki Kinugasa, Koji Ogawa, Ayaka Asano, Kelly A. Whelan, Naoya Sakamoto, Koji Nakagawa, Mitsuteru Natsuizaka, Fumiyuki Sato, Hiroshi Takeda, Seiji Naganuma, Tomoe Shimazaki, Masato Nakai, Shunsuke Ohnishi, Goki Suda, Shinya Ohashi, Megumi Kimura, Takuya Sho, Osamu Maehara, Hiroshi Nakagawa, Yoshiyuki Fujimoto, Shingo Kagawa, Yoshito Komatsu, Kenichi Morikawa
In esophageal squamous cell carcinoma (ESCC), a subset of cells defined by high expression of CD44 and low expression of CD24 has been reported to possess characteristics of cancer stem-like cells (CSCs). Novel therapies directly targeting CSCs have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1737fa77ec65a78371d7ab3b093f46
https://europepmc.org/articles/PMC5862278/
https://europepmc.org/articles/PMC5862278/
Autor:
Mitsuteru Natsuizaka, Masato Nakai, Takuya Sho, Yoshimasa Kubota, Ayaka Asano, Goki Suda, Hiroshi Takeda, Jun Itoh, Naoya Sakamoto, Hiroshi Nakagawa, Koji Ogawa, Kelly A. Whelan, Fumiyuki Sato, Kenichi Morikawa, Shunsuke Ohnishi, Yoshito Komatsu, Yoko Tsukuda, Seiji Tsunematsu, Osamu Maehara, Makoto Chuma, Koji Nakagawa, Katsumi Terashita
Publikováno v:
Cancer biologytherapy. 16(10)
In hepatocellular carcinoma (HCC), there exists a highly tumorigenic subset of cells defined by high expression of CD44 and CD133 that has been reported to contain cancer stem-like cells (CSCs). Kruppel-like factor 5 (KLF5) regulates many factors inv
Autor:
Goki Suda, Kenichi Morikawa, Ayaka Asano, Takuya Sho, Shunsuke Ohnishi, Masato Nakai, Seiji Tsunematsu, Yoko Tsukuda, Fumiyuki Sato, Mitsuteru Natsuizaka, Katsumi Terashita, Jun Itoh, Osamu Maehara, Yoshimasa Kubota, Koji Ogawa, Naoya Sakamoto
Publikováno v:
Gastroenterology. 148:S-43
Introduction: There exists a highly tumorigenic subset of hepatocellular carcinoma (HCC) cells defined by high expression of CD44 and CD133, and that subset has been reported to contain cancer stem-like cells (CSCs) in HCC. Kruppel-like factor 5 (KLF
Autor:
Osamu Maehara, Goki Suda, Mitsuteru Natsuizaka, Shunsuke Ohnishi, Yoshito Komatsu, Fumiyuki Sato, Masato Nakai, Takuya Sho, Kenichi Morikawa, Koji Ogawa, Tomoe Shimazaki, Megumi Kimura, Ayaka Asano, Yoshiyuki Fujimoto, Shinya Ohashi, Shingo Kagawa, Hideaki Kinugasa, Seiji Naganuma, Whelan, Kelly A., Hiroshi Nakagawa
Publikováno v:
Carcinogenesis; Nov2017, Vol. 38 Issue 11, p1073-1083, 11p